Labcorp Holdings Inc
LH265.640USD
+4.170+1.59%
收盤 11/21, 16:00（美東）報價延遲15分鐘
22.05B總市值
25.78本益比TTM
關於 Labcorp Holdings Inc 公司
Labcorp Holdings Inc. 提供全面的實驗室服務，幫助醫生、醫院、製藥公司、研究人員和患者做出清晰而自信的決定。該公司通過其無與倫比的診斷和藥物開發能力提供見解並加速改善健康和改善生活。該公司通過兩個部門運營：診斷實驗室 (Dx) 和生物製藥實驗室服務 (BLS)。診斷實驗室部門包括常規測試和專業/深奧測試。Dx 通過患者服務中心、分支機構、快速反應實驗室、初級實驗室和專業實驗室網絡運營。生物製藥實驗室服務部門包括早期開發研究實驗室和中央實驗室服務。該公司專注於四個主要專業測試領域，例如腫瘤學、女性健康、自身免疫性疾病和神經病學。
Labcorp Holdings Inc簡介
公司代碼LH
公司名稱Labcorp Holdings Inc
上市日期Apr 24, 1991
CEOMr. Adam H. Schechter
員工數量70000
證券類型Ordinary Share
年結日Apr 24
公司地址358 S Main St
城市BURLINGTON
上市交易所NYSE Consolidated
國家United States of America
郵編27215
電話13362291127
網址https://www.labcorp.com/
公司代碼LH
上市日期Apr 24, 1991
CEOMr. Adam H. Schechter
Labcorp Holdings Inc公司高管
名稱
名稱/職務
職務
持股
持股變動
Mr. Adam H. Schechter
Mr. Adam H. Schechter
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
87.57K
-6.16%
Dr. Brian J. Caveney, M.D., J.D.
Dr. Brian J. Caveney, M.D., J.D.
Executive Vice President, President, Early Development Research Laboratories, Chief Medical and Scientific Officer
Executive Vice President, President, Early Development Research Laboratories, Chief Medical and Scientific Officer
30.07K
-6.24%
Mr. Lance V. Berberian
Mr. Lance V. Berberian
Executive Vice President - Special Advisor, Strategy
Executive Vice President - Special Advisor, Strategy
22.53K
+9.59%
Mr. Peter M. Neupert
Mr. Peter M. Neupert
Independent Director
Independent Director
12.89K
--
Dr. Garheng Kong, M.D., Ph.D.
Dr. Garheng Kong, M.D., Ph.D.
Lead Independent Director
Lead Independent Director
12.84K
--
Ms. Kerrii B. Anderson, CPA
Ms. Kerrii B. Anderson, CPA
Independent Director
Independent Director
8.67K
-31.58%
Ms. Amy B. Summy
Ms. Amy B. Summy
Executive Vice President, Chief Marketing Officer
Executive Vice President, Chief Marketing Officer
5.30K
+16.66%
Mr. Mark S. Schroeder
Mr. Mark S. Schroeder
Executive Vice President and President, Diagnostics Laboratories and Chief Operations Officer
Executive Vice President and President, Diagnostics Laboratories and Chief Operations Officer
4.96K
--
Mr. Akinbolade Oyegunwa
Mr. Akinbolade Oyegunwa
Executive Vice President and Chief Information and Technology Officer
Executive Vice President and Chief Information and Technology Officer
3.73K
+7.59%
Ms. Megan D. Bailey
Ms. Megan D. Bailey
Executive Vice President and President - Central Laboratories and International
Executive Vice President and President - Central Laboratories and International
3.59K
+5.61%
查看更多
名稱
名稱/職務
職務
持股
持股變動
Mr. Adam H. Schechter
Mr. Adam H. Schechter
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
87.57K
-6.16%
Dr. Brian J. Caveney, M.D., J.D.
Dr. Brian J. Caveney, M.D., J.D.
Executive Vice President, President, Early Development Research Laboratories, Chief Medical and Scientific Officer
Executive Vice President, President, Early Development Research Laboratories, Chief Medical and Scientific Officer
30.07K
-6.24%
Mr. Lance V. Berberian
Mr. Lance V. Berberian
Executive Vice President - Special Advisor, Strategy
Executive Vice President - Special Advisor, Strategy
22.53K
+9.59%
Mr. Peter M. Neupert
Mr. Peter M. Neupert
Independent Director
Independent Director
12.89K
--
Dr. Garheng Kong, M.D., Ph.D.
Dr. Garheng Kong, M.D., Ph.D.
Lead Independent Director
Lead Independent Director
12.84K
--
Ms. Kerrii B. Anderson, CPA
Ms. Kerrii B. Anderson, CPA
Independent Director
Independent Director
8.67K
-31.58%
收入明細
單位: USD更新時間: 3月12日 週三
單位: USD更新時間: 3月12日 週三
FY2021
FY2020
FY2019
由於公司未披露，未能獲取相關數據
地區USD
名稱
營收
佔比
Northern America
13.09B
81.22%
Europe
2.05B
12.72%
Other Countries
976.40M
6.06%
業務
地區
由於公司未披露，未能獲取相關數據
股東統計
更新時間: 11月16日 週日
更新時間: 11月16日 週日
持股股東
股東類型
持股股東
持股股東
佔比
The Vanguard Group, Inc.
11.79%
BlackRock Institutional Trust Company, N.A.
5.30%
State Street Investment Management (US)
4.62%
Victory Capital Management Inc.
3.18%
Geode Capital Management, L.L.C.
2.56%
其他
72.54%
持股股東
持股股東
佔比
The Vanguard Group, Inc.
11.79%
BlackRock Institutional Trust Company, N.A.
5.30%
State Street Investment Management (US)
4.62%
Victory Capital Management Inc.
3.18%
Geode Capital Management, L.L.C.
2.56%
其他
72.54%
股東類型
持股股東
佔比
Investment Advisor
50.29%
Investment Advisor/Hedge Fund
38.90%
Research Firm
2.40%
Pension Fund
1.76%
Hedge Fund
1.60%
Bank and Trust
1.56%
Sovereign Wealth Fund
1.25%
Individual Investor
0.37%
Family Office
0.26%
其他
1.61%
機構持股
更新時間: 10月1日 週三
更新時間: 10月1日 週三
報告期間
機構數
持股數
持股佔比
持股變動
2025Q3
1802
83.09M
100.23%
+765.81K
2025Q2
1825
81.46M
98.03%
-5.42M
2025Q1
1872
81.69M
97.58%
-5.17M
2024Q4
1872
81.10M
96.90%
-5.32M
2024Q3
1856
80.09M
95.55%
-6.82M
2024Q2
1876
81.29M
96.43%
-7.49M
2024Q1
1904
82.39M
97.73%
-8.65M
2023Q4
1947
83.11M
99.02%
-9.76M
2023Q3
1930
84.34M
99.29%
-7.18M
2023Q2
1934
84.05M
94.75%
-3.56M
查看更多
股東持股明細
名稱
持股數
佔比
持股變動
變動比例
公告日期
The Vanguard Group, Inc.
9.84M
11.84%
+155.62K
+1.61%
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
4.40M
5.3%
-203.29K
-4.41%
Jun 30, 2025
State Street Investment Management (US)
3.86M
4.65%
+36.00K
+0.94%
Jun 30, 2025
Victory Capital Management Inc.
2.20M
2.64%
+2.14M
+3588.62%
Jun 30, 2025
Geode Capital Management, L.L.C.
2.11M
2.54%
+44.63K
+2.16%
Jun 30, 2025
Wellington Management Company, LLP
1.82M
2.19%
+1.55M
+584.94%
Jun 30, 2025
Allspring Global Investments, LLC
2.00M
2.41%
+43.51K
+2.22%
Jun 30, 2025
Select Equity Group, L.P.
2.13M
2.57%
-87.26K
-3.93%
Jun 30, 2025
Diamond Hill Capital Management Inc.
1.82M
2.19%
-128.08K
-6.56%
Jun 30, 2025
Nordea Funds Oy
1.83M
2.2%
+401.81K
+28.15%
Jun 30, 2025
查看更多
持股ETF
更新時間: 11月6日 週四
更新時間: 11月6日 週四
機構名稱
佔比
iShares U.S. Healthcare Providers ETF
3.89%
Knowledge Leaders Developed World ETF
3.18%
Thrivent Small-Mid Cap ESG ETF
2.26%
SPDR S&P Health Care Services ETF
2%
Brandes US Value ETF
1.75%
Invesco S&P 500 Equal Weight Health Care ETF
1.73%
Madison Covered Call ETF
1.69%
Nuveen ESG Mid-Cap Value ETF
1.57%
Schwab Ariel Opportunities ETF
1.49%
iShares ESG Aware MSCI USA Value ETF
1.43%
查看更多
iShares U.S. Healthcare Providers ETF
佔比3.89%
Knowledge Leaders Developed World ETF
佔比3.18%
Thrivent Small-Mid Cap ESG ETF
佔比2.26%
SPDR S&P Health Care Services ETF
佔比2%
Brandes US Value ETF
佔比1.75%
Invesco S&P 500 Equal Weight Health Care ETF
佔比1.73%
Madison Covered Call ETF
佔比1.69%
Nuveen ESG Mid-Cap Value ETF
佔比1.57%
Schwab Ariel Opportunities ETF
佔比1.49%
iShares ESG Aware MSCI USA Value ETF
佔比1.43%
分紅派息
近5年累計派現
692.30M
美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
Jan 09, 2025
LH.NB Interim Cash Dividend of gross USD 0.72 paid on Mar 12, 2025 going ex on Feb 27, 2025
Feb 27, 2025
Mar 12, 2025
Feb 27, 2025
Oct 10, 2024
LH.NB Final Cash Dividend of gross USD 0.72 paid on Dec 13, 2024 going ex on Nov 26, 2024
Nov 26, 2024
Dec 13, 2024
Nov 26, 2024
Jul 25, 2024
LH.NB Interim Cash Dividend of gross USD 0.72 paid on Sep 13, 2024 going ex on Aug 29, 2024
Aug 29, 2024
Sep 13, 2024
Aug 29, 2024
Apr 11, 2024
LH.NB Interim Cash Dividend of gross USD 0.72 paid on Jun 12, 2024 going ex on May 24, 2024
May 28, 2024
Jun 12, 2024
May 24, 2024
Jan 12, 2024
LH.NB Interim Cash Dividend of gross USD 0.72 paid on Mar 13, 2024 going ex on Feb 26, 2024
Feb 27, 2024
Mar 13, 2024
Feb 26, 2024
Oct 12, 2023
LH.NB Final Cash Dividend of gross USD 0.72 paid on Dec 12, 2023 going ex on Nov 07, 2023
Nov 08, 2023
Dec 12, 2023
Nov 07, 2023
Jul 13, 2023
LH.NB Interim Cash Dividend of gross USD 0.72 paid on Sep 08, 2023 going ex on Aug 07, 2023
Aug 08, 2023
Sep 08, 2023
Aug 07, 2023
Apr 06, 2023
LH.NB Interim Cash Dividend of gross USD 0.72 paid on Jun 08, 2023 going ex on May 17, 2023
May 18, 2023
Jun 08, 2023
May 17, 2023
Jan 12, 2023
LH.NB Interim Cash Dividend of gross USD 0.72 paid on Mar 13, 2023 going ex on Feb 22, 2023
Feb 23, 2023
Mar 13, 2023
Feb 22, 2023
Oct 12, 2022
LH.NB Final Cash Dividend of gross USD 0.72 paid on Dec 09, 2022 going ex on Nov 16, 2022
Nov 17, 2022
Dec 09, 2022
Nov 16, 2022
查看更多
拆合股
公告日期
類型
比率
暫無數據
公告日期
類型
比率
暫無數據
常見問題
Labcorp Holdings Inc的前五大股東是誰？
Labcorp Holdings Inc的前五大股東如下：
The Vanguard Group, Inc.持有股份：9.84M佔總股份比例：11.84%。
BlackRock Institutional Trust Company, N.A.持有股份：4.40M佔總股份比例：5.30%。
State Street Investment Management (US)持有股份：3.86M佔總股份比例：4.65%。
Victory Capital Management Inc.持有股份：2.20M佔總股份比例：2.64%。
Geode Capital Management, L.L.C.持有股份：2.11M佔總股份比例：2.54%。
The Vanguard Group, Inc.持有股份：9.84M佔總股份比例：11.84%。
BlackRock Institutional Trust Company, N.A.持有股份：4.40M佔總股份比例：5.30%。
State Street Investment Management (US)持有股份：3.86M佔總股份比例：4.65%。
Victory Capital Management Inc.持有股份：2.20M佔總股份比例：2.64%。
Geode Capital Management, L.L.C.持有股份：2.11M佔總股份比例：2.54%。
Labcorp Holdings Inc的前三大股東類型是什麼？
Labcorp Holdings Inc 的前三大股東類型分別是：
The Vanguard Group, Inc.
BlackRock Institutional Trust Company, N.A.
State Street Investment Management (US)
The Vanguard Group, Inc.
BlackRock Institutional Trust Company, N.A.
State Street Investment Management (US)
有多少機構持有Labcorp Holdings Inc(LH)的股份？
截至2025Q3，共有1802家機構持有Labcorp Holdings Inc的股份，合計持有的股份價值約為83.09M，占公司總股份的100.23% 。與2025Q2相比，機構持股有所增加，增幅為2.20%。
哪個業務部門對Labcorp Holdings Inc的收入貢獻最大？
在FY2021，--業務部門對Labcorp Holdings Inc的收入貢獻最大，創收--，占總收入的--% 。
